Navigation Links
Myostatin gene could hold the key to treatment for DMD

Recent studies to establish an effective treatment for Duchenne Muscular Dystrophy (DMD) have discovered that drugs or molecules used to inhibit myostatin - a protein that inhibits muscle growth - might prove to be the anticipated// answer.

MDA grantee Kathryn Wagner of John Hopkins University showed in a new study, published online, that muscle mass and strength in mice with DMD is increased by the loss of the myostatin gene. She teamed with Hopkins geneticist Se-Jin Lee to create a strain of mice lacking the myostatin gene which were later bred with mice with DMD. They found that the offspring had significantly larger, stronger muscles than diseased mice with an intact myostatin gene and the offspring also had less fibrosis (the replacement of muscle by fat and connective tissue).

Another similar study was carried out by Tejvir S. Khurana of the University of Pennsylvania who used antimyostatin antibody, developed by scientists from Wyeth Pharmaceuticals of Cambridge, and studied its effect on mice with DMD. He injected the antibody into the abdominal cavity of mice with DMD before they showed signs of the disease. After three months, he found that the mice injected with the antibody had increased muscle mass and strength in their leg muscles, and less degeneration and fibrosis of their respiratory muscles, when compared to untreated mice. They also had lower blood levels of creatine kinase (CK) — a protein that leaks out of damaged muscle.

While Kathryn believes that there is a real possibility for moving forward in clinical trials with myostatin inhibition, Khurana is more cautious, noting that the myostatin-blocking antibodies he used were made in mouse cells to target mouse myostatin and that it is necessary to make specific human antibodies before proceeding to clinical trials. However, Kathryn indicated that there are other ways of inhibiting myostatin and that antibodies are farthest in the pipeline.

Khurana cauti
'"/>




Page: 1 2

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...scientists working at the epicenter of the AIDS ep...an immunodeficiency virus// (HIV) “exhausts” kille...he researchers found that HIV can simply “turn off...r switch on the cells. In test tube studies, howev...
...problems in cataract surgery is higher in patients... treat an enlarged prostate.// According to the 3...thalmology, the American Society of Cataract and R...ogical Association, mentioning the use of drugs li...
...d have been the cause of the recent U.S. outbreak ...solution according to researchers on Tuesday.// W... received multiple reports of the corneal infectio... solution Renu with MoistureLoc was recalled from ...
...ho are anxious before surgery have a more complica...was conducted by the Yale School of Medicine// stu...diatrics, Children who are anxious before surgery ...omplicated postoperative recovery. Zeev Kain, M.D...
Other Medicine News:Health News:How HIV "Exhausts" Killer T Cells 2Health News:How HIV "Exhausts" Killer T Cells 3Health News:How HIV "Exhausts" Killer T Cells 4Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3Health News:Corneal infections Linked to External Contamination 2Health News:Anxiety In Children Prior To Surgery Might Complicate Recovery 2
(Date:10/9/2008)...Newswire-FirstCall/ -- Diamyd Medical reports,that... New England Journal,of Medicine, has published an...the Diamyd(R) diabetes vaccine for type 1 diabetes...080314/297194 ), The article is now available on...d will be in print on October 30. It presents the,...
(Date:10/8/2008)...Pioneers Research That May Offer New Hope to,Heart...- Nationally, over 3,000 people are,waiting for a ... only half,of those will receive a transplant. Now...AHI) is paving the way for how to treat congestive...media News Release, go to:, http://www.prnewswire....
(Date:10/8/2008)...otency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO...aceuticals,Corporation (TSX: NVN) today presented ...roprietary Toll-like Receptor 3 agonist, Poly IC-P...ress 2008 in Lyon, France.,Study results demonstra...ting the Toll-like Receptor 3 (TLR3) pathway. Data...
(Date:10/7/2008)...Newswire/ -- McLaren Health Care and its Great,Lak...d,s leading medical,minds to share the latest work...estinal cancer treatments. The October 11th sympos...McLaren,s Sukamal Saha, M.D., an,award-winning sur...ng for,colorectal cancer has gained worldwide reco...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2Lessons from evolution applied to national security and other threats 2033 1Lessons from evolution applied to national security and other threats 2033 2Lessons from evolution applied to national security and other threats 2033 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 1Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 2Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 4Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 5Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 6JDRF to establish an autoimmunity center at University of Colorado Denver 10275 1JDRF to establish an autoimmunity center at University of Colorado Denver 10275 2
... Calif., May 17, 2007 /PRNewswire-FirstCall/ -- DU...maceutical has,provided its shareholders with an u...Memryte, an investigational drug for the,treatment...shareholders that they have observed positive outc...ng men. DURECT has not,independently verified the ...
... Md., May 18, 2007 /PRNewswire-FirstCall/ -- Vanda... present four,posters on iloperidone at the 160th ...ing which will be held at the San,Diego Convention...24, 2007. , The following posters will be presente...San Diego Convention Center (Sails,Pavilion, Upper...
Other Medicine Technology:DURECT Provides an Update to the Memryte Program Under Development,by Voyager Pharmaceutical Corp 2Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting 2
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: